Van­da los­es con­sti­tu­tion­al fight over FDA's drug talks with com­peti­tors

The FDA dodged claims from Van­da Phar­ma­ceu­ti­cals that it al­leged­ly vi­o­lat­ed the US Con­sti­tu­tion by rec­om­mend­ing the same drug spec­i­fi­ca­tions for both Van­da and its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.